Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Formulation in Adults With IBS-D
NCT05509725Phase 4Recruiting
- Sponsor
- Lallemand Health Solutions
- Start
- Aug 2022
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Irritable bowel syndrome with diarrhea (IBS-D) (2 arms), sponsored by Lallemand Health Solutions. Primary endpoints: Change in Abdominal Pain at 8 weeks and Change in Defecation consistency at 8 weeks. Started Aug 2022; status: recruiting.
02
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT05509725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05509725.